A drug-free migraine treatment

Breaking News

Nerivio Selected for TIME’s 2019 Best Inventions

Red More

Clinically proven and drug-free – Nerivio is an innovative  remote electrical neuromodulation (REN) wearable for the acute treatment of migraine applied to the upper-arm

66.7% of

achieve pain relief at 2 hours
(Yarnitsky et al., Headache, 2019)

Non – invasive
Non – addictive
Non – pharmacological

Smart &

How Nerivio works

The patient starts a treatment as early as possible and always within 60 minutes of migraine headache or aura onset

To maximize the clinical benefit of the treatment, the treatment intensity should be set to a level that feels strong yet comfortable and painless

The patient can continue with his/her everyday activities without the migraine symptoms

Meet Nerivio

Nerivio is a wireless non-invasive remote electrical stimulation wearable applied to the upper arm at the onset of migraine headache or aura. Nerivio induces an inherent pain inhibition brain mechanism, resulting in a clinically significant pain relief. Nerivio is safe and well-tolerated.


Nerivio is controlled by an easy-to-use app that provides personalized treatments and offers an advanced migraine diary to track treatment sessions and migraine headaches. The migraine diary can be shared between patients and their healthcare professionals to improve migraine management.

Read More


“I tried many types of painkillers; nothing was helpful. The device helped me keep the pain level to the lowest level. When using the device, I don’t suffer from photophobia and I never had to take medication. It is small and easy to use.”


C.B, Migraine Patient

“This wearable device is completely novel. It fills a gap as not everybody who has migraine responds to over the counter or migraine-specific treatments.”

Dr. Brian Grosberg

“I would pay whatever it takes to get one. I have been on every medication and have tried every alternative therapy that is out. At this point I am more desperate than ever.”

J.R, Migraine Patient

“Providing the migraine patient community with safe and effective alternative is important, and remote electrical neuromodulation looks very promising.”

Dr. Alan Rapoport

Nerivio is FDA authorized



Nerivio is indicated for acute treatment of migraine with or without aura in patients 18 years of age or older who do not have chronic migraine. It is a prescription use, self-administered device for use in the home environment at the onset of migraine headache or aura.



Nerivio should not be used by people with congestive heart failure, severe cardiac or cerebrovascular disease, or uncontrolled epilepsy.  Nerivio should not be used by anyone with active implantable medical devices (eg, pacemaker, hearing aid implant). It should only be applied on the upper arm over dry, healthy skin with normal physical sensation and without any metallic implants or in proximity to cancerous lesions. Nerivio has not been evaluated in pregnancy or those under the age of 18. For full use instructions and safety information, please see the Nerivio User Manual.